Literature DB >> 27206713

Synovial fluid proteins are required for the induction of interleukin-1β production by monosodium urate crystals.

A Scanu1, F Oliviero1, L Gruaz2, P Galozzi1, R Luisetto3, R Ramonda1, D Burger2, L Punzi1.   

Abstract

OBJECTIVES: Monosodium urate (MSU) crystal deposition in gouty joints promotes the release of inflammatory mediators, in particular interleukin (IL)-1β. The induction of IL-1β production by MSU crystals requires a co-stimulus. The objective of this study was to determine which part of the synovial fluid (SF) provides co-stimulation to MSU crystals to induce IL-1β in macrophages.
METHOD: The lipidic fraction (LF) and the protein fraction (PF) were isolated from the SF of patients with arthropathies. The PF was subfractionated according to different molecular weight (MW) ranges. THP-1 cells or human primary monocytes were stimulated with MSU crystals in the presence or absence of SF or SF fractions. IL-1β and IL-8 production and IL-1β mRNA expression were assessed by an enzyme-linked immunosorbent assay (ELISA) and quantitative real-time polymerase chain reaction (qPCR).
RESULTS: Exposure of monocytes/macrophages to MSU crystals alone induced the moderate release of IL-8 but not of IL-1β. The production of IL-1β required the presence of both SF from patients with inflammatory arthritis (SFi) and MSU crystals. SF from patients with non-inflammatory arthritis, that is patients with osteoarthritis (OA), did not affect the IL-1β production but slightly enhanced the secretion of IL-8. Both MSU crystals and SFi were required for the induction of the IL-1β transcript, which was not expressed in the presence of either stimulus alone. SFi fractionation demonstrated that the MSU crystal co-stimulus was contained in the PF of SFi with MW > 50 kDa but not in the LF.
CONCLUSIONS: This study shows that the SF of inflammatory arthritis patients, including gout patients, contains proteins required for the induction of IL-1β by MSU crystals in macrophages whereas lipids are not involved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27206713     DOI: 10.3109/03009742.2015.1124452

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  7 in total

1.  Identification in synovial fluid of a new potential pathogenic player in arthropathies.

Authors:  Anna Scanu; Mariagrazia Lorenzin; Roberto Luisetto; Paola Galozzi; Augusta Ortolan; Francesca Oliviero; Andrea Doria; Roberta Ramonda
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-26

Review 2.  Exploring the Link between Uric Acid and Osteoarthritis.

Authors:  Cheryl Ann Ma; Ying Ying Leung
Journal:  Front Med (Lausanne)       Date:  2017-12-13

3.  A Brief History of IL-1 and IL-1 Ra in Rheumatology.

Authors:  Jean-Michel Dayer; Francesca Oliviero; Leonardo Punzi
Journal:  Front Pharmacol       Date:  2017-05-23       Impact factor: 5.810

Review 4.  How Factors Involved in the Resolution of Crystal-Induced Inflammation Target IL-1β.

Authors:  Francesca Oliviero; Anna Scanu
Journal:  Front Pharmacol       Date:  2017-03-28       Impact factor: 5.810

Review 5.  Autoinflammatory Mechanisms in Crystal-Induced Arthritis.

Authors:  Francesca Oliviero; Sara Bindoli; Anna Scanu; Eugen Feist; Andrea Doria; Paola Galozzi; Paolo Sfriso
Journal:  Front Med (Lausanne)       Date:  2020-04-30

6.  Polydatin and Resveratrol Inhibit the Inflammatory Process Induced by Urate and Pyrophosphate Crystals in THP-1 Cells.

Authors:  Francesca Oliviero; Yessica Zamudio-Cuevas; Elisa Belluzzi; Lisa Andretto; Anna Scanu; Marta Favero; Roberta Ramonda; Giampietro Ravagnan; Alberto López-Reyes; Paolo Spinella; Leonardo Punzi
Journal:  Foods       Date:  2019-11-07

7.  Degenerative joint disease induced by repeated intra-articular injections of monosodium urate crystals in rats as investigated by translational imaging.

Authors:  Nathalie Accart; Janet Dawson; Michael Obrecht; Christian Lambert; Manuela Flueckiger; Julie Kreider; Shinji Hatakeyama; Peter J Richards; Nicolau Beckmann
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.